Tag

503a

All articles tagged with #503a

health-policy1 month ago•4 min saved

FDA Panel Backs Six Peptides for Compounding, But Legal Access Hangs on Rulemaking

An FDA Pharmacy Compounding Advisory Committee narrowly recommended six of seven peptides for inclusion on the 503A Bulks List—BPC-157, KPV, TB-500, MOTS-c, Semax, and Epitalon—with emideltide rejected. The vote advances a nonbinding advisory step, but none of the substances is FDA-approved and final access hinges on proposed and final rulemaking. Available studies are short and small, leaving safety and efficacy data weak. The panel's reconstitution drew scrutiny over conflicts of interest, and payers should expect continued out-of-pocket use and online sourcing, with emphasis on careful medication reconciliation and safety monitoring until more data are available.

via ajmc.com|

#503a #compounding #fda

health1 month ago•9 min saved

FDA panel weighs allowing compounding of experimental peptides amid safety concerns

An FDA advisory committee will review seven experimental peptides to decide if they should be added to the 503A Bulks List, potentially letting state-licensed compounding pharmacies prepare them with prescriptions. Regulators say there is insufficient evidence on safety and effectiveness, raising concerns about long-term risks, while advocates argue a regulated pathway could reduce unsafe online sourcing. The decision is advisory, with final regulatory choices falling to the agency and potentially reshaping access to these non-FDA-approved peptides.

via CNN|

#503a #compounding #fda